Together, these findings thus indicated that miR-657 is able to drive NSCLC cell invasiveness, proliferation, and EMT induction by suppressing SRCIN1 expression and modulating the Slug pathway within these tumor cells in vitro. This evidence concerns the gene SRCIN1 and neoplasm.